These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20117161)

  • 21. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.
    Arias HR
    Biochim Biophys Acta; 1998 Aug; 1376(2):173-220. PubMed ID: 9748559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of the calcium dynamics of the human alpha4beta2, alpha3beta4 and alpha1beta1gammadelta nicotinic acetylcholine receptors.
    Michelmore S; Croskery K; Nozulak J; Hoyer D; Longato R; Weber A; Bouhelal R; Feuerbach D
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):235-45. PubMed ID: 12172706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel positive allosteric modulators of the human α7 nicotinic acetylcholine receptor.
    Arias HR; Gu RX; Feuerbach D; Guo BB; Ye Y; Wei DQ
    Biochemistry; 2011 Jun; 50(23):5263-78. PubMed ID: 21510634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.
    Arias HR; López JJ; Feuerbach D; Fierro A; Ortells MO; Pérez EG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2420-30. PubMed ID: 23954208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topology of ligand binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Brain Res Brain Res Rev; 1997 Oct; 25(2):133-91. PubMed ID: 9403137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors.
    Arias HR; Bhumireddy P; Spitzmaul G; Trudell JR; Bouzat C
    Biochemistry; 2006 Feb; 45(7):2014-26. PubMed ID: 16475790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
    Whiteaker P; Sharples CG; Wonnacott S
    Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High affinity binding of epibatidine to serotonin type 3 receptors.
    Drisdel RC; Sharp D; Henderson T; Hales TG; Green WN
    J Biol Chem; 2008 Apr; 283(15):9659-65. PubMed ID: 17702741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of ketamine on intraspinal acetylcholine release: involvement of spinal nicotinic receptors.
    Abelson KS; Goldkuhl RR; Nylund A; Höglund AU
    Eur J Pharmacol; 2006 Mar; 534(1-3):122-8. PubMed ID: 16612840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations alpha2beta4, alpha3beta4 and alpha4beta4 stably expressed in HEK293 cells.
    Stauderman KA; Mahaffy LS; Akong M; Veliçelebi G; Chavez-Noriega LE; Crona JH; Johnson EC; Elliott KJ; Gillespie A; Reid RT; Adams P; Harpold MM; Corey-Naeve J
    J Pharmacol Exp Ther; 1998 Feb; 284(2):777-89. PubMed ID: 9454827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bupropion and its photoreactive analog (±)-SADU-3-72 interact with luminal and non-luminal sites at human α4β2 nicotinic acetylcholine receptors.
    Arias HR; Feuerbach D; Ortells MO
    Neurochem Int; 2016 Nov; 100():67-77. PubMed ID: 27612850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula.
    Arias HR; Jin X; Feuerbach D; Drenan RM
    Int J Biochem Cell Biol; 2017 Nov; 92():202-209. PubMed ID: 29042244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of interaction of 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester with Torpedo californica nicotinic acetylcholine receptor and 5-hydroxytryptamine3 receptor.
    Sun H; McCardy EA; Machu TK; Blanton MP
    J Pharmacol Exp Ther; 1999 Jul; 290(1):129-35. PubMed ID: 10381768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cotinine binding to nicotinic acetylcholine receptors in bovine chromaffin cell and rat brain membranes.
    Vainio PJ; Tuominen RK
    Nicotine Tob Res; 2001 May; 3(2):177-82. PubMed ID: 11403732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis for epibatidine selectivity at desensitized nicotinic receptors.
    Pennington RA; Gao F; Sine SM; Prince RJ
    Mol Pharmacol; 2005 Jan; 67(1):123-31. PubMed ID: 15496507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Agonist self-inhibitory binding site of the nicotinic acetylcholine receptor.
    Arias HR
    J Neurosci Res; 1996 Apr; 44(2):97-105. PubMed ID: 8723217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alkaloids Purified from
    Arias HR; Ortells MO; Feuerbach D; Burgos V; Paz C
    J Nat Prod; 2019 Jul; 82(7):1953-1960. PubMed ID: 31276409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying the binding site(s) for antidepressants on the Torpedo nicotinic acetylcholine receptor: [3H]2-azidoimipramine photolabeling and molecular dynamics studies.
    Sanghvi M; Hamouda AK; Jozwiak K; Blanton MP; Trudell JR; Arias HR
    Biochim Biophys Acta; 2008 Dec; 1778(12):2690-9. PubMed ID: 18817747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different interaction between the agonist JN403 and the competitive antagonist methyllycaconitine with the human alpha7 nicotinic acetylcholine receptor.
    Arias HR; Gu RX; Feuerbach D; Wei DQ
    Biochemistry; 2010 May; 49(19):4169-80. PubMed ID: 20377277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.